.

Steven A. Johnston

Portrait of Steven A. Johnston

Steven defends health care professionals and corporate entities in medical malpractice litigation. He approaches each case with a thoughtful, detail-driven mindset, and a focus on achieving successful resolutions. Steven leverages his strong research, writing, and analytical skills to deliver clear strategies and persuasive advocacy on behalf of his clients.

Prior to joining the firm, Steven served as a law clerk in a major felonies criminal courtroom in Philadelphia and a dependency/delinquency courtroom in Tucson, Arizona. He was also a summer law clerk in Federal District Court for the Eastern District of Pennsylvania with the Hon. Joel Slomsky. The first several years of his practice were with the Department of Veterans Affairs (VA) where he authored 675 administrative appellate decisions. While with the VA, Steven helped create and was voted the first president of PrideVA, the Department’s first employee resource group.

Steven earned his juris doctor from the Temple University Beasley School of Law, where he participated on the Moot Court team and in the Law and Public Policy Scholars program. He also created a name change clinic for low income transgender individuals.

Outside of work, Steven enjoys creating stained glass art at a local studio, gardening, and spending time with his two rescue dogs.

    • Temple University Beasley School of Law (J.D., 2018)
    • La Salle University (B.A., 2014)
    • New Jersey, 2024
    • Pennsylvania, 2019
    • New York, 2026
    • U.S. District Court District of New Jersey, 2026
    • U.S. Court of Appeals 3rd Circuit, 2026
    • Essex County Bar Association, LGBTQ Section Co-Chair (2025-present)
    • New Jersey State Bar Association, LGBTQ Section Legislative Coordinator (2025-present)
    • Historical Practices and Policies Affecting LGBTQ Service Members in the U.S. Military, Essex County Bar Association,  December 15, 2025

Thought Leadership

The Quarterly Dose

Casual Care, Serious Consequences: How Informal Prescribing Can Trigger Medical Board Scrutiny

June 11, 2026

The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Consider the following scenario: in December 2025, a medical provider renewed a prescription for a long-standing telemedicine patient receiving a Schedule II controlled dangerous substance. This was not a violation of the New Jersey Administrative Code. Another provider doing the same action for an equally situated patient in March 2026 would be in violation. The casual prescriber who is not aware of newer regulatory requirements may have a more difficult time responding to a medical board complaint. Medicine is a highly-regulated helping profession. Without addressing the merits of this regulatory burden, the practice of medicine continues to see drastic changes impacting the everyday life of patient and provider. Telemedicine, COVID-19, and other advances and roadblocks, present a challenge to those saving lives while attempting to comply with the rules of practice. Physicians often discover—through real cases and the lens of regulatory expectations—that even well-intentioned informal help can be reinterpreted as stepping outside mandated professional boundaries, and seemingly harmless actions can be construed as deviations from required practice standards specifically outlined in Title 13, Chapter 35, Subchapters 7.1A of the New Jersey Administrative Code. Title 45, "Professions and Occupations," of the New Jersey code governs the practice of medicine, nursing, optometry, pharmacy, and many other professional occupations. Section 9 specifically addresses the state board of medical examiners and allows for the creation of rules and regulations in Section 45:9-5.3. These regulations can be found in the New Jersey Administrative Code Title 13, Chapter 35. While broad in scope, Chapter 35 contains a subchapter dedicated to the administration and dispensing of prescription drugs. Such knowledge will arm physicians with the tools they need to prevent a negative outcome if a medical board complaint is filed. Likewise, attorneys must be familiar with these regulatory requirements when advising and defending providers. In New Jersey, N.J.A.C. Section 13:35-7.1A(a) requires that a practitioner conduct an examination and appropriately document the same within the medical record before dispensing drugs or issuing prescriptions. The examination must include an "appropriate history and physical examination," a diagnosis based upon the examination and any testing consistent with good medical care, the formulation of a therapeutic plan discussed with the patient, and the availability of appropriate follow-up care. There are only six exceptions to this requirement: In admission orders for a newly hospitalized patient For a patient of another physician for whom the practitioner is taking calls For continuation medications on a short-term basis for a new patient prior to the patient's first appointment For an established patient who, based on sound medical practice, the physician believes does not require a new examination before issuing a new prescription For a patient examined by a healthcare professional who is in collaborative practice with the practitioner When treatment is provided by a practitioner for an emergency medical condition Emergencies are also limited to situations where someone's health is in serious jeopardy, there is serious impairment to bodily functions, or serious dysfunction of any bodily organ or part. During the COVID-19 pandemic, then New Jersey Governor Phil Murphy issued an executive order declaring a public health emergency and a state of emergency that allowed authorized prescribers to prescribe Schedule II controlled dangerous substances via telemedicine. The order was terminated when he left office earlier this year and the state reverted to the requirement of an initial in-person examination and quarterly in-person visits. With this return to prior regulatory requirements, practitioners subject to the jurisdiction of the board of medical examiners may benefit from a refresher on the regulatory limitations on their practice now that the pandemic-era flexibilities have ended. This new requirement may create confusion for prescribers and lead to casual prescribing of medication in violation of the regulations, even in the setting of recurrent telemedicine appointments as noted in the example above. Casual prescribing can take many forms: filling a prescription request from a friend or family member without an examination or contemporary medical record; using telemedicine to expand your practice without proper in-person appointments or documentation in the medical record; failing to ensure appropriate follow-up care for a "one time" prescription; etc. Although not all board complaints end in a publicly available opinion, serious deviations from regulatory requirements can shine a light on practices that will require action by the board if a complaint is received. Consider the following cases: In October 2025, the board issued a final consent order in an administrative action where a doctor provided opioids without examination and his license was permanently revoked. In re Robert Dela Gente, D.O., N.J. State Bd. of Med. Exam'rs Oct. 21, 2025. Criminal charges were filed (though that is not always the case). In a September 2025 consent order, a physician was reprimanded for "prescribing opioids several months in advance without the proper patient follow-up..." and explained that they did so for "patients who can not pay for multiple visits to refill medications." In re A/an E. Schultz, M.D., N.J. State Bd. of Med. Exam'rs Sept. 25, 2025. Another physician was suspended and placed on probation in a consent order for prescribing three patients the weight-loss medication "Ozempic" via text messages through a website called "Push Health" and without any further communication with the patients or taking a medical history. In re Laura E. Purdy, M.D., N.J. State Bd. of Med. Exam'rs Aug. 29, 2025. A June 2025 interim consent order required a "full evaluation and assessment of [a physician's] general knowledge and skill, with specific emphasis on his knowledge of and ability to safely prescribe [controlled dangerous substances]" due to his failure to review a patient's prior medical history and medical record, assess and review the prescription monitoring program before prescribing CDS, and conduct random urine screens on a patient that tested positive for CDS upon admission to his practice because "he trusted the patient." In re Donald Oh, M.D., N.J. State Bd. of Med. Exam'rs June 2, 2025. Each of these examples demonstrate a failure to follow strict procedure regardless of the intention. Failing to follow procedure secondary to good intentions, such as considering a patient's financial constraints, trust in the patient, or utilizing a new telemedicine service platform, will not be a defense to a board complaint. Especially when practicing via telemedicine, practitioners must ensure they are adhering to the appropriate regulatory standard. A provider who calls in a prescription for a traveling friend or family member or agrees to prescribe medication for individuals using the newest phone app will have a hard time meeting the requirements of N.J.A.C. Section 13:35-7.1A. Even if a history was taken, a "therapeutic plan" was created, and "follow up care" was provided, the prescriber would still not be in compliance with the regulation without an in-person examination. In our opening hypothetical, the prescriber's behavior did not change between December and March; however, the legal shift in the regulatory landscape made once acceptable behavior a violation as a required examination did not occur. When complaints are made with regard to informal prescribing, the board has discretion to employ measures to encourage compliance in lieu of formal proceedings such as a private, written warning; suspending fines subject to continuing compliance; medical or professional treatment as may be necessary; medical or diagnostic testing and monitoring; skills assessment; corrective training; participation in outreach programming; or contribution to the consumer fraud protection fund. The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Even compliant providers who had not conducted an in-person examination for telemedicine patients during the COVID-19 emergency would be in violation of the regulations as of January 2026 for the same practice. Practitioners should be diligent in adhering to the prescribing rules to avoid sanctions related to casual care. Likewise, attorneys advising or defending practitioners before the board must be aware of the in-person examination requirements for prescribing in New Jersey whether the care in question took place in-person or in a telemedicine setting. Reprinted with permission from the April 22, 2026 issue of the New Jersey Law Journal. ©2026 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved.

New Jersey Law Journal

Casual Care, Serious Consequences: How Informal Prescribing Can Trigger Medical Board Scrutiny

April 22, 2026

The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met.

Firm Highlights

Thought Leadership

U.S. Department of Education Reports to Congress on Disciplinary Removals of Children with Disabilities

In June 2026, the United States Department of Education, through the Office of Special Education and Rehabilitative Services (OSERS), published its “47th Annual Report to Congress on the Implementation of the Individuals with Disabilities Education Act, 2025.” In its report, OSERS provided detailed data and information on the discipline and removal of students from their educational placements, specifically for the school year 2022-2023. To obtain this data, all 50 states, the District of Columbia, the Bureau of Indian Education, Puerto Rico, and other U.S. territories, were asked to report on pre-school and school-aged students, ages 3-21, who were served under IDEA, Part B, and removed from their educational placements for disciplinary reasons during the school year in question. Not all jurisdictions had data available; OSERS’ reporting to Congress was based on the information supplied by the jurisdictions that responded.  First, OSERS examined the total number of served students who were removed to an interim alternative educational setting. From the reporting data, this number totaled 7,204,199 students. Of this total, 11,364 students were removed unilaterally by school personnel for drugs, weapons, or serious bodily injury to themselves or others. These figures reflected the unilateral removal of served students at a rate of 16 per 10,000 students. Of this total, 545 students were removed by a due process hearing officer for likely serious bodily injury, a rate of one per 10,000 students.  Next, OSERS examined data for students who were suspended (in school and out of school) or expelled for more than 10 school days. The total number of students in this category was 7,623,095. Of this total, 65,104 students received out of school suspensions or expulsions, a rate of 85 per 10,000 students. A total of 21,878 students received in school suspensions, a rate of 29 students per 10,000.  OSERS evaluated this particular data and drilled down further, examining the rate of interim removal, expulsion, and suspension per 10,000 students based specifically upon each IDEA disability category. Perhaps not surprisingly, children primarily identified with emotional disturbance were the most affected.    For every 10,000 students who were identified under the category of emotional disturbance, 65 were unilaterally removed to an interim alternative educational setting by school personnel (not the IEP team) for drugs, weapons, or serious bodily injury, and four out of every 10,000 students were removed following a hearing officer finding that there was a substantial likelihood of serious bodily injury to the student or others. By contrast, the ratio of students under each of the other disability categories who were unilaterally removed by school personnel was 25 or less per 10,000 students in each category. No more than two students per 10,000 in each of the other categories were removed by a hearing officer. Other Health Impairment was the second leading category.  For every 10,000 students identified primarily with emotional disturbance, 411 students received out of school suspensions or expulsions of more than 10 days, and 107 of every 10,000 students in this category received in-school suspensions. In comparison, the ratio of students under each of the other disability categories who received out of school suspensions or expulsions of more than 10 days was no more than 172 per 10,000. Students identified in all other disability categories received in-school suspensions at a rate of no more than 57 per 10,000 students. Again, Other Health Impairment was the second leading category. OSERS then examined discipline data with a state-by-state comparison, once more at a ratio of 10,000 students served. The overall data of students who were unilaterally removed to an interim alternative educational setting by school personnel for drugs, weapons, or serious bodily injury showed that removal occurred most frequently in Texas (92 per 10,000 students), Montana (62 per 10,000 students), and Tennessee (42 per 10,000 students). The mean was 12.1.  In Pennsylvania, the rate of removal was 12 out of every 10,000 students, just below the mean.  OSERS also considered, on a state-by-state basis, the number of students who received out-of-school suspensions or expulsions of greater than 10 days. The most significant rate of discipline here occurred in North Carolina (256 per 10,000 students), Missouri (250 per 10,000 students), and South Carolina (250 per 10,000 students).  The mean was 85.83. In Pennsylvania, the rate of discipline was 57 per 10,000 students, well below the mean.  Finally, OSERS evaluated, on a state-by-state comparison, the ratio of students per 10,000 who were identified under the category of emotional disturbance and who received out of school suspensions or expulsions for greater than 10 days. The suspension or expulsion of students with emotional disturbance occurred most often in North Carolina (1,723 per 10,000 students), Missouri (1,127 per 10,000 students), and South Carolina (1,098 per 10,000). The mean was 485.81. In Pennsylvania, the suspension or expulsion of students identified with emotional disturbance occurred at a rate of 260 per 10,000, again well below the mean. Although OSERS did not draw any specific conclusions about the disciplinary data it collected, it is nonetheless evident that students primarily identified with emotional disturbance were removed from their educational placements for disciplinary reasons at a rate much higher than students in any other disability category. Relatively speaking, however, Pennsylvania acquitted itself well in the state-by-state disciplinary data collection.

Thought Leadership

Pennsylvania HB 2307: Special Education Contingency Fund Reform

Pennsylvania school districts and school law attorneys are aware of the increasing cost of special education services. In an effort to address this growing squeeze on school district budgets, a bi-partisan group of Pennsylvania House Representatives introduced House Bill 2307. The bill is a special education funding measure intended to reform Pennsylvania's reimbursement system for extraordinarily high-cost special education students. As written, HB 2307 would increase funding dedicated to Pennsylvania's Extraordinary Special Education Program Expenses reimbursement program. Beginning with the 2026-27 school year, the bill would increase the set-aside from 1% to 2% of the annual Special Education appropriation. The increased funding is aimed at assisting school districts and charter schools address the costs of serving students whose needs generate exceptionally high special education expenses. The proposal specifically targets situations involving students whose annual special education costs exceed the state's highest cost threshold and represent a significant burden on a district's special education budget. HB 2307 includes key eligibility requirements such as: 1) extraordinary special education expenses approved by the Secretary of Education; 2) student costs exceeding the state's highest Category 3A threshold; 3) costs representing at least 1% of the district's total special education expenditures; 4) student enrolled in the district for no more than two consecutive school years for the proposed reimbursement category; and 5) application and documentation requirements for districts and charter schools. HB 2307 successfully passed the Pennsylvania House of Representatives on June 16, 2026, by a unanimous vote of 202-0. It was subsequently transmitted to the Senate and was referred to the Senate Education Committee on June 22, 2026, where it currently remains pending. While there is currently no scheduled Senate committee or floor vote publicly listed for HB 2307, the next step would be for the Senate Education Committee to consider the bill and determine whether to report it to the full Senate for consideration. If approved by the committee, the bill would proceed through the Senate's three-consideration process before a final vote. Because the General Assembly is still within the 2025-26 legislative session, the bill remains eligible for action during the remainder of the session. However, absent committee action, it will not become law before the start of the 2026-27 school year. If enacted, HB 2307 could have several important effects: Greater financial stability for districts serving students with exceptionally expensive educational and related-service needs. Increased reimbursement opportunities for high-cost placements, specialized transportation, intensive behavioral supports, and other extraordinary services. Reduced pressure on local special education budgets, particularly in smaller districts where one or two high-cost students can significantly affect annual expenditures. Potential reduction in litigation and placement disputes driven by financial constraints, although the bill does not alter substantive IDEA rights or district obligations to provide FAPE.